In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Net income | -10.4 | -14.3 | -7.2 | -7.8 | -5.1 | -5.7 | -9.7 | -7.9 |
Depreciation and amortization | 2.1 | 1.3 | 1.0 | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 |
Asset impairment charges | 0.1 | 0.0 | | | | | | |
Stock-based compensation | 4.6 | 7.6 | 4.1 | 1.2 | 0.8 | 1.8 | 1.1 | 1.1 |
Change in working capital [+] | -1.2 | 1.0 | 1.0 | 0.4 | -0.3 | 0.6 | 0.4 | -0.4 |
Accounts receivable | | | | | -0.1 | -0.1 | 0.0 | 0.2 |
Other current assets | -0.2 | -0.4 | -0.2 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
Deferred revenues | | | | | | 0.8 | 0.3 | 0.1 |
Other | -1.0 | 1.3 | 1.2 | 0.9 | -0.3 | -0.2 | 0.1 | -0.8 |
Other operating activities | -0.1 | -0.6 | -0.8 | -0.1 | 2.4 | 1.2 | 5.2 | 1.2 |
Cash from operations | -5.0 | -5.0 | -1.9 | -5.6 | -1.6 | -1.6 | -2.3 | -5.5 |
|
Capital expenditures [+] | -1.2 | -1.5 | -1.2 | -0.4 | -0.4 | -0.4 | 0.0 | -0.2 |
Purchases of property and equipment | -0.1 | -0.1 | | -0.1 | 0.0 | 0.0 | | |
Capitalized product costs | -1.2 | -1.4 | -1.2 | -0.3 | -0.4 | -0.4 | | -0.2 |
Purchases of intangible assets | | | | | | | 0.0 | 0.0 |
Other cash from investing | -4.5 | -0.1 | -0.1 | | 0.0 | | | |
Cash from investing | -5.7 | -1.6 | -1.3 | -0.4 | -0.4 | -0.4 | 0.0 | -0.3 |
|
Issuance of common stock, net | -0.8 | 16.5 | 7.8 | | 5.6 | 1.6 | 2.1 | 0.3 |
Option exercises | | 0.6 | 1.3 | 2.3 | 0.0 | | | |
Other cash from financing | -0.6 | 0.6 | 3.8 | 4.5 | 0.3 | 1.0 | 0.0 | 5.4 |
Cash from financing | -1.3 | 16.5 | 10.3 | 2.2 | 5.9 | 2.6 | 2.1 | 5.8 |
|
Free cash flow | -5.1 | -5.1 | -1.9 | -5.7 | -1.7 | -1.7 | -2.3 | -5.5 |
Per share (diluted) | ($0.54) | ($0.59) | ($0.33) | ($0.74) | ($0.30) | ($0.44) | ($0.02) | ($0.07) |
|
Cash paid for interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | | 0.0 |
Cash paid for income taxes | 0.0 | 0.0 | | | | | | |